Blood Glucose 156 mg/dL in HHS: Stop Insulin, Start Dextrose
When a patient with hyperosmolar hyperglycemic state (HHS) reaches a blood glucose of 156 mg/dL, you must immediately start 5% or 10% dextrose infusion and reduce or stop the insulin infusion to prevent hypoglycemia while continuing to correct the hyperosmolality. 1
Critical Management Algorithm at Glucose 156 mg/dL
Immediate Actions Required:
Dextrose Administration:
- Start 5% or 10% dextrose infusion immediately 1
- This prevents hypoglycemia while allowing continued osmolality correction
- The FDA label confirms dextrose is indicated for maintaining glucose levels and preventing rebound hypoglycemia when concentrated dextrose is withdrawn 2
Insulin Adjustment:
- Reduce the fixed-rate intravenous insulin infusion (FRIII) significantly 1
- In many cases, insulin can be stopped entirely at this glucose level in HHS
- The target glucose range for HHS in the first 24 hours is 10-15 mmol/L (180-270 mg/dL), so 156 mg/dL is actually below target 1
Why This Differs from Standard Hyperglycemia Management
The Joint British Diabetes Societies (JBDS) guidelines specifically emphasize that HHS management differs fundamentally from DKA 1, 3. In HHS:
- The primary goal is gradual osmolality reduction (3.0-8.0 mOsm/kg/h), not rapid glucose normalization 1
- Blood glucose should remain 10-15 mmol/L (180-270 mg/dL) during the first 24 hours 1
- Rapid glucose correction risks neurological complications including osmotic demyelination syndrome 3
At 156 mg/dL (8.7 mmol/L), your patient's glucose is too low for optimal HHS management in the acute phase.
Monitoring Requirements
Continue close monitoring of:
- Blood glucose hourly initially
- Serum osmolality every 2-4 hours (target reduction 3-8 mOsm/kg/h) 1
- Potassium levels (hypokalaemia occurs in ~50% of cases) 4, 2
- Sodium levels (expect initial rise with treatment) 3
- Clinical status and urine output (target ≥0.5 mL/kg/h) 1
Common Pitfall to Avoid
The most dangerous error is treating HHS like routine hyperglycemia or DKA. Standard inpatient glucose targets of 140-180 mg/dL 4, 5 do not apply during acute HHS management. Aggressive glucose lowering in HHS increases the risk of:
- Cerebral edema
- Central pontine myelinolysis
- Osmotic demyelination syndrome 3
The JBDS guidelines explicitly state that insulin should be withheld until glucose stops falling with IV fluids alone (unless significant ketonaemia is present) 3. At 156 mg/dL, you are well past the point where aggressive insulin is appropriate.
Resolution Criteria
Continue this modified approach until HHS resolves, defined as:
- Osmolality <300 mOsm/kg
- Hypovolaemia corrected
- Cognitive status returned to baseline
- Blood glucose <15 mmol/L (270 mg/dL) 1
Only after resolution should you transition to standard subcutaneous insulin regimens targeting conventional glucose ranges 5.